A new study of prostate cancer patients by Seattle researchers found that those who took statins were significantly less likely to die from their disease than those not taking the drugs.
John Schieszer has the latest on the story in today’s Medical Minute.
Next post in The Medical Minute
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.